I. Llorente

929 total citations
35 papers, 378 citations indexed

About

I. Llorente is a scholar working on Rheumatology, Epidemiology and Immunology. According to data from OpenAlex, I. Llorente has authored 35 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 10 papers in Epidemiology and 10 papers in Immunology. Recurrent topics in I. Llorente's work include Rheumatoid Arthritis Research and Therapies (14 papers), Inflammatory Myopathies and Dermatomyositis (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). I. Llorente is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (14 papers), Inflammatory Myopathies and Dermatomyositis (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). I. Llorente collaborates with scholars based in Spain and United States. I. Llorente's co-authors include Santos Castañeda, Isidoro González‐Álvaro, Cristina Valero, Rosario García‐Vicuña, Raquel Almodóvar, Beatriz Joven, María Jesús García de Yébenes, Laura Nuño, L. Lojo and Patrícia Carreira and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the Rheumatic Diseases and Value in Health.

In The Last Decade

I. Llorente

33 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Llorente Spain 11 206 154 76 60 50 35 378
Olga Kryštůfková Czechia 13 153 0.7× 190 1.2× 146 1.9× 146 2.4× 37 0.7× 36 458
Beatriz Teresita Martín-Márquez Mexico 12 142 0.7× 110 0.7× 94 1.2× 96 1.6× 49 1.0× 33 365
Liuyan Nie China 11 133 0.6× 51 0.3× 53 0.7× 56 0.9× 44 0.9× 16 314
David Veigl Czechia 10 152 0.7× 169 1.1× 145 1.9× 125 2.1× 82 1.6× 21 569
Marco Bardelli Italy 10 124 0.6× 44 0.3× 49 0.6× 84 1.4× 24 0.5× 51 335
Jana Tomasová Studýnková Czechia 7 129 0.6× 224 1.5× 80 1.1× 54 0.9× 15 0.3× 7 327
Yasuyuki Kamata Japan 11 125 0.6× 81 0.5× 54 0.7× 193 3.2× 33 0.7× 30 455
Erika Aurora Martínez-García Mexico 12 139 0.7× 56 0.4× 75 1.0× 132 2.2× 45 0.9× 26 383
B. Manger Germany 10 350 1.7× 52 0.3× 48 0.6× 66 1.1× 50 1.0× 20 523
S. Vagnani Italy 10 356 1.7× 65 0.4× 60 0.8× 169 2.8× 39 0.8× 13 554

Countries citing papers authored by I. Llorente

Since Specialization
Citations

This map shows the geographic impact of I. Llorente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Llorente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Llorente more than expected).

Fields of papers citing papers by I. Llorente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Llorente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Llorente. The network helps show where I. Llorente may publish in the future.

Co-authorship network of co-authors of I. Llorente

This figure shows the co-authorship network connecting the top 25 collaborators of I. Llorente. A scholar is included among the top collaborators of I. Llorente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Llorente. I. Llorente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández‐Cruz, Blanca, J. Rosas, Cèsar Díaz‐Torné, et al.. (2022). Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study). Rheumatology and Therapy. 9(2). 589–608. 11 indexed citations
2.
Pulito‐Cueto, Verónica, Sara Remuzgo‐Martínez, Fernanda Genre, et al.. (2021). Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy. Clinical and Experimental Rheumatology. 40(5). 988–992. 2 indexed citations
3.
Llorente, I., et al.. (2020). Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons. Frontiers in Medicine. 7. 601618–601618. 87 indexed citations
4.
Pulito‐Cueto, Verónica, Sara Remuzgo‐Martínez, Fernanda Genre, et al.. (2020). Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis.. PubMed. 38(6). 1201–1205. 10 indexed citations
5.
Valero, Cristina, et al.. (2020). AB0334 COST-EFECTIVENESS OF JAK INHIBITORS IN RHEUMATOID ARTHRITIS IN THE REAL WORL PRACTICE. Annals of the Rheumatic Diseases. 79. 1465–1466. 2 indexed citations
6.
7.
Llorente, I., et al.. (2019). Factores asociados a la persistencia a largo plazo de rituximab en artritis reumatoide en la práctica clínica: Estudio RITAR. Medicina Clínica. 155(1). 1–8. 1 indexed citations
8.
López, Jorge López, I. Llorente, Alicia Humbría, et al.. (2019). Rituximab induces a lasting, non-cumulative remodelling of the B-cell compartment.. PubMed. 37(4). 615–622. 9 indexed citations
9.
Castañeda, Santos, Sara Remuzgo‐Martínez, Raquel López‐Mejías, et al.. (2018). Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis.. PubMed. 37(3). 465–473. 38 indexed citations
10.
11.
López, Jorge López, I. Llorente, Alberto García-Vadillo, et al.. (2018). Experience With the Use of Rituximab for the Treatment of Rheumatoid Arthritis in a Tertiary Hospital in Spain. JCR Journal of Clinical Rheumatology. 25(6). 258–263. 6 indexed citations
12.
Llorente, I., Ana M. Ortiz, Rosario García‐Vicuña, et al.. (2017). Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients. Rheumatology International. 37(5). 799–806. 39 indexed citations
13.
Nuño, Laura, Beatriz Joven, Patrícia Carreira, et al.. (2017). Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain. Rheumatology International. 37(11). 1853–1861. 48 indexed citations
14.
Llorente, I., et al.. (2016). Nuevas perspectivas en el tratamiento de la artritis reumatoide. 14(4). 275–280. 4 indexed citations
15.
16.
Nuño, Laura, Beatriz Joven, Patrícia Carreira, et al.. (2016). Registro de pacientes con miopatía inflamatoria de la Sociedad Madrileña de Reumatología: análisis descriptivo. Reumatología Clínica. 13(6). 331–337. 15 indexed citations
17.
Llorente, I., et al.. (2015). SAT0288 Atypical Femoral Fractures After Treatment with Bisphosphonates and Denosumab in Inflammatory and Senile Osteoporosis. Annals of the Rheumatic Diseases. 74. 762–763. 1 indexed citations
18.
Llorente, I., et al.. (1996). [The therapeutic applications of octreotide].. PubMed. 106(13). 505–16. 1 indexed citations
19.
Llorente, I., et al.. (1991). [Spontaneous tumor regression in a patient with metastatic gastric cancer. Communication of an additional case].. PubMed. 34(3). 141–2. 3 indexed citations
20.
Goñi, Fernando, et al.. (1991). [Treatment with octreotide (SMS 201-995) in a case of intestinal carcinoid tumor].. PubMed. 189(7). 331–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olga Kryštůfková Breakdown of academic impact, for papers by Beatriz Teresita Martín-Márquez Breakdown of academic impact, for papers by Liuyan Nie Breakdown of academic impact, for papers by David Veigl Breakdown of academic impact, for papers by Marco Bardelli Breakdown of academic impact, for papers by Jana Tomasová Studýnková Breakdown of academic impact, for papers by Yasuyuki Kamata Breakdown of academic impact, for papers by Erika Aurora Martínez-García Breakdown of academic impact, for papers by B. Manger Breakdown of academic impact, for papers by S. Vagnani
Rankless by CCL
2026